wt1 tcr-transduced t cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01621724)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Wilms tumor proteinImmunity, passive
immunity, passive - wt1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- wt1 tcr-transduced t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02550535 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2015 | Cell Therapy Catapult, Department of Health, United Kingdom, University of London |
| NCT01621724 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2012 | Cell Therapy Catapult, Department of Health, United Kingdom, University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cell Therapy Catapult | For profit | 2 | 2 | 1 | 2012 |
| Department of Health, United Kingdom | Government | 2 | 0 | 1 | 2012 |
| University of London | Academic/Hospital | 2 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1